Corient Private Wealth
EXEL icon

Corient Private Wealth’s Exelixis EXEL Stock Holding History

Corient Private Wealth’s Portfolio EXEL Stock Details EXEL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.32M Sell
79,337
-13,640
-15% -$664K 0.01% 964
2026
Q1 		$3.94M Buy
92,977
+8,989
+11% +$386K 0.01% 936
2025
Q4 		$3.68M Sell
83,988
-6,041
-7% -$250K 0.01% 876
2025
Q3 		$3.72M Sell
90,029
-27,801
-24% -$1.12M 0.01% 823
2025
Q2 		$5.19M Buy
117,830
+49,123
+71% +$1.96M 0.01% 695
2025
Q1 		$2.54M Buy
68,707
+22,908
+50% +$816K ﹤0.01% 892
2024
Q4 		$1.52M Buy
45,799
+24,108
+111% +$782K ﹤0.01% 1117
2024
Q3 		$563K Buy
21,691
+4,693
+28% +$117K ﹤0.01% 1666
2024
Q2 		$382K Buy
16,998
+6,798
+67% +$151K ﹤0.01% 1781
2024
Q1 		$242K Buy
10,200
+1,751
+21% +$38.9K ﹤0.01% 2007
2023
Q4 		$203K Buy
+8,449
New +$184K ﹤0.01% 2075

Other funds holding EXEL

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Corient Private Wealth's EXEL Position: Q2 2026 in Review

Corient Private Wealth reduced its Exelixis (EXEL) stake by 15% in Q2 2026, selling an estimated $664K and leaving 79,337 shares worth $4.32M. The position accounts for 0.01% of the portfolio, ranked #964.

Corient Private Wealth first reported a position in EXEL in Q4 2023 and has held it in 11 quarters since. The position peaked at $5.19M in Q2 2025. 760 funds tracked by Wall St. Rank hold EXEL as of Q2 2026.

  • Corient Private Wealth held 79,337 shares of Exelixis worth $4.32M as of Q2 2026.
  • Corient Private Wealth sold 13,640 Exelixis shares in Q2 2026, an estimated $664K.
  • Exelixis made up 0.01% of Corient Private Wealth's portfolio in Q2 2026, its #964 holding.
  • Corient Private Wealth first reported a position in Exelixis in Q4 2023 and has held it in 11 quarters since.
  • Corient Private Wealth's Exelixis position peaked at $5.19M in Q2 2025.
  • 760 funds tracked by Wall St. Rank held Exelixis as of Q2 2026.

Based on Corient Private Wealth's 13F filing for Q2 2026, filed 12 Aug 2026.